FADS1 and acute myeloid leukemia: Mouse AML cells expressing Fads1-targeting shRNAs also displayed increased CD11b expression and phagocytic capacity as well as similar morphological features to those observed in human cells (Figs. 3, F–H, and S2, G and H).